Animal Health Committee meets with State Institutions

02/ 09/ 2025

Listen to online Stop   The European Business Association’s Animal Health Committee held a working meeting with representatives of the State Scientific Research Institute for Laboratory Diagnostics and Veterinary and Sanitary Expertise and the Ukrainian Biological Certification Centre. During the discussion, the parties focused on several important topics, including the reorganisation process of the Institute and the Agency for Veterinary Immunobiological Products, readiness for GMP inspections, as well as the possible introduction of a batch release mechanism (testing each series of products). The Committee’s experts stressed that the key priority at this stage should not be the rapid adoption of new regulatory requirements, but rather the creation of strong institutions, ensuring their proper preparation, and training of personnel. At the same time, it was emphasised that Ukrainian GMP requirements should be aligned as closely as possible with European ones, rather than creating separate standards that may complicate business operations and weaken integration with the European market. Participants also highlighted the need to establish a realistic transitional period for the introduction of GMP inspections, allowing companies to properly prepare for the new rules while ensuring the stability of production processes and the uninterrupted supply of veterinary medicines. Dialogue between business and state institutions remains a crucial element in the process of reforming the regulatory environment in the veterinary medicines sector.

The European Business Association’s Animal Health Committee held a working meeting with representatives of the State Scientific Research Institute for Laboratory Diagnostics and Veterinary and Sanitary Expertise and the Ukrainian Biological Certification Centre. During the discussion, the parties focused on several important topics, including the reorganisation process of the Institute and the Agency for Veterinary Immunobiological Products, readiness for GMP inspections, as well as the possible introduction of a batch release mechanism (testing each series of products).

The Committee’s experts stressed that the key priority at this stage should not be the rapid adoption of new regulatory requirements, but rather the creation of strong institutions, ensuring their proper preparation, and training of personnel. At the same time, it was emphasised that Ukrainian GMP requirements should be aligned as closely as possible with European ones, rather than creating separate standards that may complicate business operations and weaken integration with the European market.

Participants also highlighted the need to establish a realistic transitional period for the introduction of GMP inspections, allowing companies to properly prepare for the new rules while ensuring the stability of production processes and the uninterrupted supply of veterinary medicines.

Dialogue between business and state institutions remains a crucial element in the process of reforming the regulatory environment in the veterinary medicines sector.